PROTEOFORM SCIENTIFIC IS NOW ALLUMIQS CORPORATION. NEW NAME, EXPANDED OMICS SOLUTIONS.
We are pleased to offer our customers in North America complementary products from ReSyn Biosciences and Promise Proteomics through our online store.

ReSyn Biosciences currently offers a portfolio of innovative magnetic microparticle products, MagReSyn®, designed to specifically address the requirements of bioseparation, mass spectrometry and proteomics sample preparation. The products aim to address key limitations in R&D workflows, including reproducibility and low throughput, by developing automated workflows, and enabling clinical mass spectrometry applications.

Promise Proteomics was created in 2010 as a spin-off of CEA Grenoble. This medtech is currently wholly owned by the Aguettant group and is directed by Dr. Eric Rougemond. Its business model is based on a range of services in bioproduction and on the development of products to label and quantify proteins in biological samples. Since 2013, Promise has been a partner in an innovative and ambitious R&D program that has allowed it to develop its technology, on which the diagnostic kits for personalized medical applications are based. Capitalizing on its unique know-how in the production of internal standards for protein assays and its recognized expertise in mass spectrometry-based quantification methods, Promise Proteomics is placing its skills at the service of health care professionals through its mAb-X-mise kits